Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

F. Hoffmann-La Roche

F. Hoffmann-La Roche
1896 FOUNDED
PUBLIC STATUS
90K-95K EMPLOYEES
ROG STOCK SYMBOL
75 INVESTMENTS
$305.10 SHARE PRICE (As of Friday Closing)
Description

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and professional diagnostics for more than half of diagnostic-related sales.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Diagnostic Equipment
Drug Delivery
Stock Exchange
SWX
Primary Office
  • Grenzacherstrasse 124
  • 4070 Basel
  • Switzerland

+41 061 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore F. Hoffmann-La Roche’s full profile, request a free trial.

F. Hoffmann-La Roche Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$234.88 - $310.66 $261B $307.70 $13.87 1.72M 856M

F. Hoffmann-La Roche Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 248,423,245 225,095,871 232,206,530 216,980,142
Revenue 59,511,077 58,089,107 54,134,842 51,321,184
EBITDA 19,735,837 18,851,420 17,114,244 18,081,544
Net Income 11,871,256 10,729,614 8,768,384 9,717,092
Total Assets 82,094,487 79,749,934 78,715,519 75,399,973
Total Debt 20,034,806 19,064,741 19,464,321 21,942,051
Public Fundamental Data provided by Morningstar, Inc. disclaimer

F. Hoffmann-La Roche Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore F. Hoffmann-La Roche‘s full profile, request access.

Request full access to PitchBook

F. Hoffmann-La Roche Competitors (54)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mallinckrodt Corporate Backed or Acquired Staines-Upon-Thames, United Kingdom 0000 00.00 000000000000 00.00
00000 000000000 Formerly VC-backed Burlington, MA 00000 000000&0
000000 Corporate Backed or Acquired Holzkirchen, Germany 00000 00000000000
00000000 Corporate Backed or Acquired Basel, Switzerland 000000 000000000000
000000 Corporation North Chicago, IL 000000 000.00 000000000 000.00
To view this company’s complete list of competitors, request access »

F. Hoffmann-La Roche Investments & Acquisitions (75)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 15-Nov-2019 000000000000000000 00.000 Drug Discovery
000000 00000000000 30-Apr-2019 00000 00000 00 0000 Decision/Risk Analysis
00000 000000000000 24-Feb-2019 000000000000000000 00.00 Drug Discovery 0000000 000000
0000 000000000000 01-Oct-2018 000000000000000000 00000 Biotechnology
Medilink (Diagnostics Supply Business) 05-Sep-2018 Merger/Acquisition Diagnostic Equipment
To view this company’s complete investment and acquisition history, request access »

F. Hoffmann-La Roche Exits (16)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 24-Sep-2014 00000 00000 00 0000 Completed
  • 7 buyers
000000000 00000000 17-Dec-2012 000000000 Completed
  • 0. 00000000-00 000
0000 0000000000000 14-Sep-2012 00000 00000 00 000 Completed
  • 6 buyers
000000 0000000 20-Dec-2010 000000000000000000 00000 Completed
  • 0. 00000000-00 000
Medingo 28-May-2010 Merger/Acquisition 00000 Completed
To view this company’s complete exits history, request access »

F. Hoffmann-La Roche Subsidiaries (20)

Company Name Industry Location Founded
Flatiron Enterprise Systems (Healthcare) New York, NY 2012
000000 Other Healthcare Services Vienna, Austria 0000
000000 Drug Discovery San Diego, CA 0000
0000000000 0000000 Diagnostic Equipment Cambridge, MA 0000
00000 000000000000 Biotechnology Mountain View, CA 0000
To view this company’s complete subsidiary history, request access »

F. Hoffmann-La Roche Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore F. Hoffmann-La Roche‘s full profile, request access.

Request full access to PitchBook

F. Hoffmann-La Roche Executive Team (29)

Name Title Board
Seat
Contact
Info
Severin Schwan Chief Executive Officer & Member of the Board of Directors
Alan Hippe JD Chief Financial and IT Officer
Frank Fanien Ph.D Head of Digital Health Solutions Roche Diagnostics CPS & Senior Vice President
Gottlieb Keller JD General Counsel & Secretary, Board of Directors
Levi Garraway Chief Medical Officer & Head, Global Product Development

19 Former Executives

You’re viewing 5 of 29 executives. Get the full list »

F. Hoffmann-La Roche Board Members (13)

Name Representing Role Since Contact
Info
0000é 00000000 F. Hoffmann-La Roche Vice Chairman 000 0000
0000000 0000 F. Hoffmann-La Roche Board Member 000 0000
0000000 0000000 F. Hoffmann-La Roche Member Board of Directors 000 0000
000000000 00000 Self Chairman 000 0000
0000000 0000000000 00.0 F. Hoffmann-La Roche Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 13 board members. Get the full list »